Please select the market sector you are interested in.
Please select the university you are interested in.
Show only Easy Access opportunities.
Narrow your search with a few keywords.
Sign up to our technology alerts and be the first to hear about any new technology opportunities from Scotland's universities
Certain types of university intellectual property can sometimes prove difficult to commercialise through traditional routes, usually because it is at an early stage of development, or because it presents enough uncertainty for companies to risk an investment.
University Technology’s Easy Access portal offers access to this type of intellectual property at no cost, to enable companies to evaluate it and put it to use quickly, with reduced risk.
Easy Access uses quick and simple licence agreements to fast-track the transfer of knowledge and expertise from Scotland’s universities to industry, so that these technologies may be developed for the benefit of the economy and society.
Through this initiative, our aim is to make it easier for Scottish universities and industry to work together and build strong, long-term relationships with industry partners.
Showing 41 - 50 of 85 opportunities
This luminance control technology characterises Electronic Visual Displays (EVDs) to accurately replicate a set of predetermined luminance levels across the entire display to meet light sensitivity requirements for vision assessment testing and vision-based research.
Researchers at the University of Edinburgh have developed a visual field testing device that uses a strategy that is more natural for the patient than current gold standard tests resulting in an improved patient experience.
Researchers at the University of Aberdeen have developed a low-cost, high-precision measurement device to determine the purity of any fluid from the interference pattern of two beams of light that traverse a fluid sample. The device can be deployed for remote monitoring and reduces time and cost of ...
Unique antigenic domains of PfEMP1 a key parasite surface molecule implicated in development of severe malaria. Antibodies to these molecules stimulate cross strain immunity to both lab strains and clinical isolates of malaria parasites.
OSCAR™ is a gene amplification system with the potential to simplify the method of protein production in cultured mammalian cells.
A more efficient and lower cost method for synthesis of triphosphates using a polymer-supported reagent that eliminates many of the processing stages of other systems generating far greater yields and higher purity material.
This compound screening technology works for, though not limited to, challenging screening targets. It can discriminate compounds that are cell permeable, show specific binding affinity to the target and forewarn of drug cytotoxicity in a single step.
Adherent glioma neural stem (GNS) cell lines that retain the characteristics of the original tumour-initiating cells, delivering a powerful model system for chemical and genetic screening.
This irrigating solution with superior chondro-protective properties reduces damage to cartilage cells (chondrocytes) during orthopaedic procedures. This helps preserve a healthy cartilage and lowers the risk of developing degenerative joint diseases, like osteoarthritis.
Aberdeen researchers have developed a novel antibody that demonstrates clear activity against C. albicans in vitro in an immune system-independent manner.